These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1862730)

  • 41. Is buspirone effective for panic disorder?
    Sheehan DV; Raj AB; Sheehan KH; Soto S
    J Clin Psychopharmacol; 1990 Feb; 10(1):3-11. PubMed ID: 2407755
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis.
    Boyer W
    Int Clin Psychopharmacol; 1995 Mar; 10(1):45-9. PubMed ID: 7622804
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia.
    Klerman GL
    J Psychiatr Res; 1990; 24 Suppl 2():27-41. PubMed ID: 1980697
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lactate vulnerability after alprazolam versus placebo treatment of panic disorder.
    Cowley DS; Dager SR; Roy-Byrne PP; Avery DH; Dunner DL
    Biol Psychiatry; 1991 Jul; 30(1):49-56. PubMed ID: 1892962
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial.
    Tesar GE; Rosenbaum JF; Pollack MH; Herman JB; Sachs GS; Mahoney EM; Cohen LS; McNamara M; Goldstein S
    J Clin Psychiatry; 1987 Oct; 48 Suppl():16-21. PubMed ID: 3312179
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
    Dunner DL; Ishiki D; Avery DH; Wilson LG; Hyde TS
    J Clin Psychiatry; 1986 Sep; 47(9):458-60. PubMed ID: 2875064
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.
    Noyes R; DuPont RL; Pecknold JC; Rifkin A; Rubin RT; Swinson RP; Ballenger JC; Burrows GD
    Arch Gen Psychiatry; 1988 May; 45(5):423-8. PubMed ID: 3358644
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discontinuation reactions to alprazolam in panic disorder.
    Pecknold JC
    J Psychiatr Res; 1993; 27 Suppl 1():155-70. PubMed ID: 8145176
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How "blind" are double-blind studies?
    Margraf J; Ehlers A; Roth WT; Clark DB; Sheikh J; Agras WS; Taylor CB
    J Consult Clin Psychol; 1991 Feb; 59(1):184-7. PubMed ID: 2002136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug treatment of panic disorder.
    Rosenberg R
    Pharmacol Toxicol; 1993 Jun; 72(6):344-53. PubMed ID: 8103214
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The relationship of alprazolam dose to steady-state plasma concentrations.
    Ciraulo DA; Antal EJ; Smith RB; Olson DR; Goldberg DA; Rand EH; Raskin RB; Phillips JP; Shader RI; Greenblatt DJ
    J Clin Psychopharmacol; 1990 Feb; 10(1):27-32. PubMed ID: 2407754
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative studies of pharmacotherapy for school refusal.
    Bernstein GA; Garfinkel BD; Borchardt CM
    J Am Acad Child Adolesc Psychiatry; 1990 Sep; 29(5):773-81. PubMed ID: 2228932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Validation criteria for panic disorder as a nosological entity.
    Rosenberg R; Ottosson JO; Bech P; Mellergård M; Rosenberg NK
    Acta Psychiatr Scand Suppl; 1991; 365():7-17. PubMed ID: 1862735
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Controlled discontinuation of benzodiazepine treatment for patients with panic disorder.
    Noyes R; Garvey MJ; Cook B; Suelzer M
    Am J Psychiatry; 1991 Apr; 148(4):517-23. PubMed ID: 2006699
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The structure of phobias in panic disorder.
    Argyle N; Solyom C; Solyom L
    Br J Psychiatry; 1991 Sep; 159():378-82. PubMed ID: 1958949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The sequence of improvement of the symptoms encountered in patients with panic disorder.
    Deltito JA; Argyle N; Buller R; Nutzinger D; Ottosson JO; Brandon S; Mellergard M; Shera D
    Compr Psychiatry; 1991; 32(2):120-9. PubMed ID: 2022110
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term effects of alprazolam and imipramine on cerebrospinal fluid monoamine metabolites and neuropeptides in panic disorder.
    Lepola U; Jolkkonen J; Rimón R; Riekkinen P
    Neuropsychobiology; 1989; 21(4):182-6. PubMed ID: 2483580
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.
    Rizley R; Kahn RJ; McNair DM; Frankenthaler LM
    Psychopharmacol Bull; 1986; 22(1):167-72. PubMed ID: 2873609
    [No Abstract]   [Full Text] [Related]  

  • 59. Clonazepam and imipramine in the treatment of panic attacks: a double-blind comparison of efficacy and side effects.
    Svebak S; Cameron A; Levander S
    J Clin Psychiatry; 1990 May; 51 Suppl():14-7; discussion 50-3. PubMed ID: 2186020
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictors of response to alprazolam and placebo in patients with panic disorder.
    Woodman CL; Noyes R; Ballenger JC; Lydiard RB; Sievers G; Mihalko D
    J Affect Disord; 1994 Jan; 30(1):5-13. PubMed ID: 8151049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.